Hepatic progenitors of the fetal liver: Interactions with hematopoietic stem cells.

Dlk1 Fetal liver Hematopoietic stem cell Hepatic stem cell Hepatoblast Liver stem cell

Journal

Differentiation; research in biological diversity
ISSN: 1432-0436
Titre abrégé: Differentiation
Pays: England
ID NLM: 0401650

Informations de publication

Date de publication:
Historique:
received: 06 11 2018
revised: 18 02 2019
accepted: 20 02 2019
pubmed: 4 3 2019
medline: 3 8 2019
entrez: 4 3 2019
Statut: ppublish

Résumé

The aim of this review is to summarize and give an overview on the findings of signaling between hepatic and hematopoietic progenitors of the liver. To date, there are not many findings published in the field, and the aim of this review is to cover all current publications in this area. The liver is the main site of hematopoiesis during fetal development. However, little is known about how hepatic and other non-hematopoietic progenitors potentially influence hematopoiesis and vice versa. The concurrent peaks of hepatic and hematopoietic progenitor proliferation during development indicate interactions that could possibly be mediated through cell-cell contact, extracellular matrices, cytokines and growth factors, or other signaling molecules. For example, hepatic progenitors, such as hepatic stem cells and hepatoblasts, possess characteristic surface markers that can be cleaved, giving rise to fragments of various lengths. A surface molecule of hepatoblasts has been demonstrated to play an essential role in hematopoiesis. Particularly, these effects on hematopoiesis were distinct, depending on whether it was membrane-bound or cleaved. In this review, the various hepatic and hematopoietic progenitor cell types are concisely described, and the current findings of their potential interactions are summarized.

Identifiants

pubmed: 30826473
pii: S0301-4681(18)30124-5
doi: 10.1016/j.diff.2019.02.005
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

9-14

Informations de copyright

Copyright © 2019 International Society of Differentiation. Published by Elsevier B.V. All rights reserved.

Auteurs

Eva Schmelzer (E)

Department of Surgery, McGowan Institute for Regenerative Medicine, University of Pittsburgh, Pittsburgh, 3025 East Carson Street, Pittsburgh, PA 15203, USA. Electronic address: schmelzere@upmc.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH